Welcome to LookChem.com Sign In|Join Free
  • or
methyl 3-(2-bromo-5-chlorophenyl)-3-oxopropanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1257230-30-0

Post Buying Request

1257230-30-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1257230-30-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1257230-30-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,2,3 and 0 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1257230-30:
(9*1)+(8*2)+(7*5)+(6*7)+(5*2)+(4*3)+(3*0)+(2*3)+(1*0)=130
130 % 10 = 0
So 1257230-30-0 is a valid CAS Registry Number.

1257230-30-0Relevant academic research and scientific papers

Formation of substituted 1-naphthols and related products via dimerization of alkyl 3-(o-halo(het)aryl)-oxopropanoates based on a CuI-catalyzed domino C-arylation/condensation/aromatization process

Weischedel, Heike,Sudheendran, Kavitha,Mikhael, Alevtina,Conrad, Jürgen,Frey, Wolfgang,Beifuss, Uwe

, p. 3454 - 3467 (2016)

Substrates bearing both a β-ketoester moiety and a (het)aryl halide structure element were dimerized to 1-naphthols and related products in the presence of catalytic amounts of CuI in isopropanol. The reaction starts with an intermolecular C-arylation, which is followed by an intramolecular condensation. The final aromatization delivers the highly substituted products with yields up to 81%.

Systematic asymmetric analog synthesis of fluspidine, a σ1 receptor ligand, to improve ligand affinity

Tanaka, Shinji,Yoshinaka, Sho,Kawamura, Kiyoshi,Morita, Mikio,Kitamura, Masato

supporting information, (2021/11/16)

Fluspidine is a high affinity ligand of the σ1 receptor. To further improve the ligand affinity, fluspidine analogs were systematically synthesized and screened herein. To design the modified ligand analogs, a docking simulation of the protein–ligand complex structure was examined. By using the developed synthetic strategy involving asymmetric catalytic 1,4-reduction of α,β -unsaturated carboxylic esters catalyzed by a chiral cobalt complex, 20 candidates of modified fluspidines were synthesized. The structure–activity relationships showed the development of a hybridized modified fluspidine. In addition, the inhibitory rate could be improved from 45% to 71%. This result demonstrates the importance of the development of a new synthetic method towards improving the ligand performance by providing a series of analogs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1257230-30-0